Definitive Healthcare (Nasdaq: DH), an industry leader in
healthcare commercial intelligence, today announced its acquisition
of Populi, a provider-focused data and analytics company that works
with healthcare organizations to optimize physician relationships,
reduce network leakage, and expand market share. This acquisition
furthers Definitive Healthcare’s commitment to leadership in the
healthcare commercial intelligence market across the entire
healthcare ecosystem, including life sciences, providers, and
diversified industries.
“Populi provides the dynamic, highly visual commercial
intelligence that healthcare organizations need to grow,” said
Robert Musslewhite, CEO of Definitive Healthcare. “Our acquisition
strategy is to find companies that either provide a new set of
proprietary data to enhance our overall offering or provide a new
capability to leverage our existing data in new use cases. Populi
checks both boxes, and we’re thrilled to have them join the
Definitive Healthcare team.”
Founded in 2020, Populi delivers healthcare commercial
intelligence for the provider market, serving some of the country’s
largest healthcare systems, including University of Pennsylvania
Health System and Henry Ford Health. Populi’s product suites
include:
- Provider
Intelligence: Helps organizations assess network
integrity, understand patient outmigration, and target
providers.
- Market
Intelligence: Enables organizations to analyze
market size and share, understand patient utilization of services,
and gain competitive insights.
- Population
Intelligence: Helps organizations segment and target
consumer audiences, build campaigns, match and append patient
records, and implement digital activation.
“Over the last few years, we focused on building a dynamic,
comprehensive solution proven to be incredibly valuable to our
provider customers,” said Bill Moschella, CEO and co-founder of
Populi. “As we looked towards the next phase of our growth,
Definitive Healthcare was the perfect company for us to join forces
with to bring our healthcare commercial intelligence to more
organizations across the care continuum. With a common vision, a
similar approach towards healthcare analytics, and a shared set of
cultural values, we couldn’t be more excited to be a part of the
Definitive Healthcare family.”
The acquisition of Populi strengthens Definitive Healthcare’s
top-ranked Atlas Dataset with new data assets and additions to
claims data, including medical and hospital records, along with
consumer-level data and social determinants of health. With this
new data from Populi, multiple departments across an organization
can gain even deeper intelligence about their market. For example,
a VP of marketing may quickly build a patient cohort analysis to
identify all knee replacement patients who recently moved long
distance to Massachusetts, while a director of business development
may first examine how many patients are leaving their primary
service area to go to competitors, then dig deeper to identify
specific physicians and individual behaviors that are driving the
macro trends.
“Populi has been an important part of our growth strategy,”
said Tanya Andreadis, Chief Marketing Officer at
University of Pennsylvania Health System. “Populi’s commercial
intelligence has helped us better understand and more
accurately target prospective patients in support of a variety of
patient acquisition programs. We’re excited to see the
combined impact of Populi and Definitive Healthcare.”
In addition to the provider-focused dataset and analytics,
Populi has a self-service portal and purpose-built tech stack that
includes API and connector technology. Populi can easily and
quickly deliver analytics to clients’ internal systems such as
Salesforce, Tableau, and AWS. Populi’s dynamic technology allows
clients to easily customize visuals by geography, timeframe,
service lines, procedure codes, providers, and patient cohort, so
they can understand their market at every level.
To learn more about Definitive Healthcare’s acquisition of
Populi, visit: https://www.definitivehc.com/populi
About Definitive Healthcare
At Definitive Healthcare, our passion is to transform data,
analytics, and expertise into healthcare commercial intelligence.
We help clients uncover the right markets, opportunities, and
people, so they can shape tomorrow’s healthcare industry. Our SaaS
platform creates new paths to commercial success in the healthcare
market, so companies can identify where to go next. Learn more
at definitivehc.com.
Forward-Looking Statements
This press release includes forward-looking
statements that reflect our current views with respect to future
events. Such statements are provided under the “safe harbor”
protection of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include all statements that do not
relate solely to historical or current facts, and can generally be
identified by words or phrases written in the future tense and/or
preceded by words such as “likely,” “should,” “may,” “will,”
“contemplates,” “anticipates,” “intends,” “plans,” “seeks,”
“believes,” “estimates,” “expects” or similar words or variations
thereof, or the negative thereof, references to future periods, or
by the inclusion of forecasts or projections. Examples of
forward-looking statements include, but are not limited to,
statements we make regarding product features and the anticipated
benefits of our acquisition of Populi.
Forward-looking statements in this press release
are based on our current expectations and assumptions regarding our
business, the economy and other future conditions. Because
forward-looking statements relate to the future, by their nature,
they are subject to inherent uncertainties, risks and changes in
circumstances that are difficult to predict. As a result, our
actual results may differ materially from those contemplated by the
forward-looking statements. Important factors that could cause
actual results to differ materially from those in the
forward-looking statements include our inability to realize
expected business or financial benefits from acquisitions and the
risk that our acquisitions or investments could prove difficult to
integrate, disrupt our business, dilute stockholder value and
adversely affect our business, financial condition and results of
operations.
Additional factors or events that could cause
our actual performance to differ from these forward-looking
statements may emerge from time to time, and it is not possible for
us to predict all of them. Should one or more of these risks or
uncertainties materialize, or should any of our assumptions prove
incorrect, our actual financial condition, results of operations,
future performance and business may vary in material respects from
the performance projected in these forward-looking statements.
For additional discussion of factors that could
impact our operational and financial results, refer to our
Amendment No. 1 on Form 10-K/A to our Annual Report on Form 10-K
for the fiscal year ended December 31, 2022, our Amendment No. 1 on
Form 10-Q/A to our Quarterly Report on Form 10-Q for the quarter
ended March 31, 2023, as well as our Current Reports on Form 8-K
and other subsequent SEC filings, which are or will be available on
the Investor Relations page of our website at ir.definitivehc.com
and on the SEC website at www.sec.gov.
All information in this press release speaks
only as of the date on which it is made. We undertake no obligation
to publicly update this information, whether as a result of new
information, future developments or otherwise, except as may be
required by law.
Media Contacts: Danielle
Johns djohns@definitivehc.com
Highwire
PR: definitivehealthcare@highwirepr.com
Investor Relations Contact: Brian
Denyeau ICR for Definitive
Healthcare brian.denyeau@icrinc.com
Definitive Healthcare (NASDAQ:DH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Definitive Healthcare (NASDAQ:DH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024